This site uses cookies.

Some of these cookies are essential, while others help us to improve your experience by providing insights into how the site is being used.

Select preferencesReject optionalAccept all

Cookie preferences

This website uses cookies so that we can provide you with the best user experience possible.

Necessary cookies (required)

Necessary cookies enable core functionality. The website cannot function properly without these cookies, which can only be disabled by changing your browser preferences.

Analytical cookies

Analytical cookies help us to improve our website by collecting and reporting information on its usage.

Submit preferencesAccept all
Generic and Biosimilar Medications

Life sciences sector plan

The government published its life sciences sector plan in July 2025. It is a comprehensive document which, for the first time ever, includes specific policy goals for the off-patent sector. This includes a stated desire to become a world leader in the uptake of off-patent medicines. We support this ambition and are working with government colleagues to realise tangible outcomes.

Generic and Biosimilar Medications

Progress

Since the sector plan was published, progress has stalled in terms of implementation. This is in large part caused by the renegotiation of the VPAG pricing scheme. Now that it is concluded, it is critical that further delays in rolling out the sector plan do not occur.

 

Life sciences can be a catalyst for broader economic growth, and the sector plan provides a pragmatic blueprint to accelerate investment. Medicines UK looks forward to working with government colleagues to bring to life the ambitions of the sector plan.

Latest industry news

Up